Kharasch, E. Et Al. 2003. Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone.. Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics , (Washington, Kiribati).

Kharasch, E., Whittington, D., ALTUNTAŞ, T., Sheffels, P., & Hoffer, C., (2003). Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone. . Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Washington, Kiribati

Kharasch, ED Et Al. "Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone.," Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Washington, Kiribati, 2003

Kharasch, ED Et Al. "Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone.." Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics , Washington, Kiribati, 2003

Kharasch, E. Et Al. (2003) . "Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone.." Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics , Washington, Kiribati.

@conferencepaper{conferencepaper, author={ED Kharasch Et Al. }, title={Role of P-glycoprotein in clinical effects of morphine, fentanyl and methadone.}, congress name={Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics}, city={Washington}, country={Kiribati}, year={2003}}